A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Children's Cancer Group, China
Dana-Farber Cancer Institute
Children's Oncology Group
St. Jude Children's Research Hospital
City of Hope Medical Center
Second Affiliated Hospital of Soochow University